Susan E. Burwig, the Executive Vice President of Operations at Medpace Holdings, Inc., recently acquired 3,000 shares of the company’s common stock. This acquisition was made through the exercise of stock options, reflecting Burwig's ongoing commitment to the company and its future prospects.
The transaction took place on October 12, 2026, at a price of $166.73 per share. Following this transaction, Burwig now holds a total of 70,984 shares in Medpace Holdings.
Background
Medpace Holdings, Inc. is a leading organization in the commercial physical and biological research sector, classified under the SIC code 8731. The company is based in Cincinnati, Ohio, and is publicly traded under the ticker symbol MEDP. Medpace provides comprehensive services to the pharmaceutical and biotechnology industries, focusing on clinical development and regulatory consulting.
What the Filing Says
The recent filing, accession number 0001677418-26-000014, indicates that Burwig exercised stock options to acquire the shares. The filing notes, "The option vested in full on October 27, 2025," allowing Burwig to exercise her right to purchase the shares.
Impact
This acquisition may positively influence investor sentiment towards Medpace, as it demonstrates a significant investment from a key executive. Burwig's actions may encourage other shareholders and potential investors to view the company favorably, given her role and the confidence she is showing in the company's direction.
What's Next
The filing does not say what happens next.